UFP Technologies, Inc. Goodwill, Foreign Currency Translation Gain (Loss)
UFP Technologies, Inc. (UFPT) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$959.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-06
- UFP Technologies, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$204.00K, a 108.52% decline year-over-year.
- UFP Technologies, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$755.00K, a 183.80% decline year-over-year.
- UFP Technologies, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was $101.00K.
- UFP Technologies, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was $26.00K, a 93.30% decline year-over-year.
- UFP Technologies, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2025 was $3.42M.
- UFP Technologies, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$1.86M, a 890.64% decline from fiscal 2023.
- UFP Technologies, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $235.00K.
- UFP Technologies, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$192.00K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$959.00K 10-Q · filed 2026-08-06 | -$858.00K derived: sum of 3 quarters · filed 2026-08-06 | -$832.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$755.00K 10-Q · filed 2026-05-08 | -$654.00K derived: sum of 2 quarters · filed 2026-05-08 | -$628.00K derived: sum of 3 quarters · filed 2026-05-08 | $1.76M derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $127.00K derived: sum of 2 quarters · filed 2026-02-27 | $2.52M derived: sum of 3 quarters · filed 2026-02-27 | $3.42M 10-K · filed 2026-02-27 |
| 2025-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.42M derived: sum of 2 quarters · filed 2025-11-07 | $3.32M 10-Q · filed 2025-11-07 | $1.28M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | $2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $3.29M 10-Q · filed 2025-08-11 | $1.26M derived: sum of 3 quarters · filed 2026-02-27 | $1.65M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | $901.00K 10-Q · filed 2025-05-12 | -$1.13M derived: sum of 2 quarters · filed 2026-02-27 | -$746.00K derived: sum of 3 quarters · filed 2026-02-27 | -$798.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | -$2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.65M derived: sum of 2 quarters · filed 2026-02-27 | -$1.70M derived: sum of 3 quarters · filed 2026-02-27 | -$1.86M 10-K · filed 2026-02-27 |
| 2024-09-30 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $336.00K derived: sum of 2 quarters · filed 2024-11-12 | $177.00K 10-Q · filed 2024-11-12 | $472.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-06-30 | -$52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$211.00K 10-Q · filed 2024-08-09 | $84.00K derived: sum of 3 quarters · filed 2025-03-03 | -$116.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-03-31 | -$159.00K 10-Q · filed 2024-05-10 | $136.00K derived: sum of 2 quarters · filed 2025-03-03 | -$64.00K derived: sum of 3 quarters · filed 2025-03-03 | -$55.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $95.00K derived: sum of 2 quarters · filed 2025-03-03 | $104.00K derived: sum of 3 quarters · filed 2025-03-03 | $235.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$191.00K derived: sum of 2 quarters · filed 2023-11-09 | -$60.00K 10-Q · filed 2023-11-09 | $554.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2023-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $140.00K 10-Q · filed 2023-08-09 | $754.00K derived: sum of 3 quarters · filed 2024-02-29 | $268.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2023-03-31 | $131.00K 10-Q · filed 2023-05-10 | $745.00K derived: sum of 2 quarters · filed 2024-02-29 | $259.00K derived: sum of 3 quarters · filed 2024-02-29 | -$172.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-12-31 | $614.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-02-29 | $128.00K derived: sum of 2 quarters · filed 2024-02-29 | -$303.00K derived: sum of 3 quarters · filed 2024-02-29 | -$192.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | -$486.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-14 | -$917.00K derived: sum of 2 quarters · filed 2022-11-14 | -$806.00K 10-Q/A · filed 2022-11-14 | |
| 2022-06-30 | -$431.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$320.00K 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | $111.00K 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |